Related Experiment Video
Updated: Oct 8, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
How to use new antibiotics in the therapy of ventilator-associated pneumonia
Toshiki Miwa1, Bryan Lizza2, Jason Burnham3
1Division of Infectious Diseases, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, Japan.
Purpose Of Review:
Ventilator-associated pneumonia (VAP) is a common nosocomial infection in critically ill patients requiring endotracheal intubation and mechanical ventilation. Recently, the emergence of multidrug-resistant Gram-negative bacteria, including carbapenem-resistant Enterobacterales, multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species, has complicated the selection of appropriate antimicrobials and contributed to treatment failure. Although novel antimicrobials are crucial to treating VAP caused by these multidrug-resistant organisms, knowledge of how to optimize their efficacy while minimizing the development of resistance should be a requirement for their use.
Recent Findings:
Several studies have assessed the efficacy of novel antimicrobials against multidrug-resistant organisms, but high-quality studies focusing on optimal dosing, infusion time and duration of therapy in patients with VAP are still lacking. Antimicrobial and diagnostic stewardship should be combined to optimize the use of these novel agents.
Summary:
Improvements in diagnostic tests, stewardship practices and a better understanding of dosing, infusion time, duration of treatment and the effects of combining various antimicrobials should help optimize the use of novel antimicrobials for VAP and maximize clinical outcomes while minimizing the development of resistance.
Insights
Novel antimicrobials are vital for treating ventilator-associated pneumonia (VAP) caused by resistant bacteria. Optimizing their use through better diagnostics and stewardship is key to improving outcomes and preventing further resistance.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pharmacology
Background:
- Ventilator-associated pneumonia (VAP) is a frequent hospital-acquired infection in mechanically ventilated patients.
- The rise of multidrug-resistant Gram-negative bacteria complicates VAP treatment and increases failure rates.
- Emerging pathogens include carbapenem-resistant Enterobacterales, multidrug-resistant Pseudomonas aeruginosa, and Acinetobacter species.
Purpose of the Study:
- To review the current landscape of novel antimicrobial use for VAP.
- To highlight the need for optimized strategies in using these agents.
- To emphasize the importance of balancing efficacy with resistance development.
Main Methods:
- Review of recent studies assessing novel antimicrobial efficacy against multidrug-resistant organisms in VAP.
- Analysis of existing data on dosing, infusion, and duration of therapy.
- Evaluation of the role of diagnostic and antimicrobial stewardship.
Main Results:
- High-quality evidence on optimal dosing, infusion, and duration for novel agents in VAP is limited.
- Multidrug-resistant organisms present significant challenges in VAP management.
- Combined antimicrobial and diagnostic stewardship is recommended.
Conclusions:
- Optimizing novel antimicrobial use in VAP requires improved diagnostic tests and stewardship practices.
- A better understanding of dosing, infusion, duration, and combination therapy is crucial.
- These improvements aim to maximize clinical outcomes and minimize antimicrobial resistance.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation I: Indication and Settings